MedPath

Electrochemical Skin Conductance in Evaluation of Chronic Neuropathy électrochimique cutanée

Not Applicable
Terminated
Conditions
Difference, Individual
Registration Number
NCT03506659
Lead Sponsor
Erasme University Hospital
Brief Summary

Use of cutaneous electrochemical conductance for preclinical screening of small-caliber nerve fibers

Detailed Description

Objective: Use of cutaneous electrochemical conductance for preclinical screening of small-caliber nerve fibers

Background:

Sudoscan is a tool developed to evaluate and screen peripheral neuropathies in diabetes. His indication has been extended to other neuropathies such as post-chemotherapy, Fabry's disease, Parkinson's disease, familial amyloid polyneuropathy.

Main objective: Evaluation of the relevance of cutaneous electrochemical conductance in chronic peripheral neuropathies.

Methodology :

Recruitment of 2 groups of 2000 patients Group 1: Patients with chronic neuropathy, during clinic bread consultation Group 2: Patients to benefit from scheduled surgery seen during anesthesia consultation For both groups filling the central awareness inventory questionnaire

Analysis of the results after the recruitment has been completed.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
4000
Inclusion Criteria
  • Adult
Exclusion Criteria
  • Patients group : Not have a chronic neuropathy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Difference of timing for Electrochemical skin conductance3 minutes

the investigators will measure the timing between the 4 members for the Electrochemical skin conductance

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

ERASME Hospital

🇧🇪

Bruxelles, Belgium

ERASME Hospital
🇧🇪Bruxelles, Belgium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.